EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 4.0

Infectious Complications During Early Treatment of Childhood Acute Lymphoblastic Leukemia—A Comparison Between the ALLTogether and NOPHO ALL‐2008 Protocols

Hannah van Bunningen iD, Johannes Fermér iD, Arja Harila, Susanna Ranta iD, Isabella Donnér, Anne Wretman, Hartmut Vogt, Anna Sällfors Holmqvist iD, Anders Valind iD, Ludvig Henriksson, Jonas Abrahamsson, Magnus Borssén und 2 weitere

Pediatric Blood & Cancer · 2026

DOI: 10.1002/pbc.32120 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Pediatric Blood & Cancer, 2026. Verfasst von Hannah van Bunningen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Women's and Children's Health, Unit for Pediatric Oncology, Karolinska Institute, Stockholm, Sweden. Hauptthemen laut MEDLINE: Precursor Cell Lymphoblastic Leukemia-Lymphoma, Antineoplastic Combined Chemotherapy Protocols, Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Infection remains the most common treatment‐related toxicity of childhood ALL, emphasizing the need to identify patients at risk and to tailor treatment strategies accordingly.

Aims

The primary aim was to compare infectious toxicity during early treatment for childhood ALL following the ALLTogether and NOPHO ALL‐2008 (ALL‐2008) protocols, and second, to identify risk factors for infectious toxicity.

Methods

A national retrospective matched cohort study was conducted, including 345 patients aged 1–17 years diagnosed with ALL and treated in Sweden according to the ALLTogether or ALL‐2008 protocols. Nonparametric tests were used to compare infectious outcomes between protocols, and regression modeling was used to identify risk factors of the infectious outcomes.

Results

Treatment following ALL‐2008 showed higher infectious toxicity during induction, whereas treatment following ALLTogether showed increased infectious toxicity during consolidation 1. Overall, treatment according to ALL‐2008 was associated with a higher incidence of infections. Anthracycline use and young age (1–9 years) were associated with both higher infectious incidence and more severe infectious complications. Dexamethasone was associated with both lower incidence and lower severity of infectious complications as compared to prednisone.

Conclusions

A notable shift in the timing of infectious toxicity was observed between the two treatment protocols. Risk factors for infectious toxicity during early treatment include anthracycline use and young age. Dexamethasone as an induction steroid was associated with lower infectious burden, although its effect is difficult to isolate from the simultaneous anthracycline effect. The findings suggest that treatment composition plays a central role in determining both the extent and timing of infectious complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precursor Cell Lymphoblastic Leukemia-LymphomaAntineoplastic Combined Chemotherapy ProtocolsInfectionsHumansChildChild, PreschoolAdolescentMaleInfantFemaleRetrospective StudiesRisk FactorsDexamethasoneFollow-Up StudiesPrednisoneIncidence

Stichwörter der Autor:innen

acute lymphoblastic leukemiachildhoodinfectionpediatrictoxicity

Substanzen

DexamethasonePrednisone

Autor:innen und Institutionen

  • Department of Women's and Children's Health, Unit for Pediatric Oncology, Karolinska Institute, Stockholm, Sweden.
  • Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
  • Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Crown Princess Victoria Children's Hospital, Region Östergötland, Linköping, Sweden.
  • Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.

ORCID-Profile: Hannah van Bunningen, Johannes Fermér, Susanna Ranta, Anna Sällfors Holmqvist, Anders Valind, Anna Nilsson

Zitieren

APA

van Bunningen, H., Fermér, J., Harila, A., Ranta, S., Donnér, I., Wretman, A., Vogt, H., Holmqvist, A. S., Valind, A., Henriksson, L., Abrahamsson, J., Borssén, M., Nilsson, A., & Heyman, M. (2026). Infectious Complications During Early Treatment of Childhood Acute Lymphoblastic Leukemia—A Comparison Between the ALLTogether and NOPHO ALL‐2008 Protocols. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.32120

Vancouver

van Bunningen H, Fermér J, Harila A, Ranta S, Donnér I, Wretman A, et al. Infectious Complications During Early Treatment of Childhood Acute Lymphoblastic Leukemia—A Comparison Between the ALLTogether and NOPHO ALL‐2008 Protocols. Pediatric Blood & Cancer. 2026. doi:10.1002/pbc.32120

BibTeX
@article{vanBunningen2026,
  author = {van Bunningen, Hannah and Fermér, Johannes and Harila, Arja and Ranta, Susanna and Donnér, Isabella and Wretman, Anne and Vogt, Hartmut and Holmqvist, Anna Sällfors and Valind, Anders and Henriksson, Ludvig and Abrahamsson, Jonas and Borssén, Magnus and Nilsson, Anna and Heyman, Mats},
  title = {Infectious Complications During Early Treatment of Childhood Acute Lymphoblastic Leukemia—A Comparison Between the ALLTogether and NOPHO ALL‐2008 Protocols},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  doi = {10.1002/pbc.32120}
}
Kostenlos starten →